Biotechnologijos institutas yra mokslinių tyrimų institucija, siekianti užtikrinti valstybės pažangą sparčiai besivystančiose gyvybės mokslų ir biotechnologijų srityse, plėtoti tarptautinio lygio molekulinės biotechnologijos tyrimus, skatinti tarpdisciplininius tyrimus bei mokslo ir verslo bendradarbiavimą
7 BENDROJI PROGRAMA
|
Small molecule inhibitors of the trimeric influenza virus polymerase complex (FLUINHIBIT). 2008-2010. dr. G.Žvirblis |
6 BENDROJI PROGRAMA
|
Meganucleases for gene replacement. 2006-2008. prof. dr. V.Šikšnys |
|
Inhibition of Cancer by Disrupting Interaction Between Polo-like Kinase 1 Polo-box Domain and Spindle Targets. 2006-2008. dr. J.Matulienė |
|
A multidisciplinary approach to the study of DNA enzymes down to the single molecule level. 2005-2009. prof. dr. V.Šikšnys |
|
Targeting newly discovered oxygen sensing cascades for novel cancer treatments, biology equipment, drugs. 2004-2008. dr. A.Kanopka |
|
Molecular modeling-based characterization of protein complexes involved in DNA repair. 2004-2006. dr. Č.Venclovas |
|
Drug design by structural thermodynamics. 2004-2006. dr. D.Matulis |
|
ScanBalt Competence Region – a model case to enhance European competitiveness in life sciences, genomics and biotechnology for health on a global scale. 2004-2006. habil. dr. A.Pauliukonis |
|
Rational design and comparative evaluation of novel genetic vaccines. 2004-2008. prof. K.Sasnauskas |
5 BENDROJI PROGRAMA
|
Support for the integration of “newly associated states” in the European research area “Biotechnology Centre of Excellence of Lithuania”. 2003-2006 |
|
Development of highly special enzymes for genome manipulation. prof. 2003-2004. dr. V.Šikšnys |
|
Enhanced Laboratory Surveillance of Measles. 2002-2005. prof. K.Sasnauskas |
|
Combined immune and gene therapy for chronic hepatitis. 2001-2003. prof. K.Sasnauskas |
|
Comprehensive risk analysis of dioxins: development of methodology to assess genetic susceptibility to developmental disturbances and cancer. 2000-2003. dr. A.Kanopkas |
|
Bivalent hantavirus vaccine for Europe: Different approaches and evaluation in animal models. 1999-2003. prof. K.Sasnauskas |
4 BENDROJI PROGRAMA
|
Molecular monitoring and pathological role of HCV, HGV and altered HBV genomes in the Baltic countries. 1998-2001. prof. K.Sasnauskas |
|
Detection, identification and typing of the Mycobacterium tuberculosis in the Baltic countries. 1998-2003. dr. P. Stakėnas |
|
Recombinant viral particulate proteins as tools for new vaccines and diagnostics. 1994-1997. prof. K.Sasnauskas |
HOWARD HUGHES MEDICINOS INSTITUTAS
|
Structural characterization of protein interactions in DNA replication, repair and recombination processes through molecular modelling. 2006-2010. dr. Č. Venclovas |
|
Towards engineering of restriction enzymes. 2003-2004. prof. dr. V. Šikšnys |
|
Bioinformatics-guided engineering of DNA methyltransferases. 2003-2004. dr. Č. Venclovas |
|
Sequence recognition and base flipping by DNA methyltransferases: Structural studies and redesign for novel functions. 2001-2005. prof. S..Klimašauskas |
|
Principles of restriction enzymes specificity. 2001-2005. prof. dr. V. Šikšnys |
|
Combination of improved methods with expert knowledge to derive models of protein structure at low sequence homology. 2001-2005. dr. Č. Venclovas |
|
Mechanisms of specific protein-DNA recognition and modification. 1996-2000. prof. S. Klimašauskas |
NACIONALINIS SVEIKATOS INSTITUTAS
|
Methylome profiling via DNA Methyltransferase directed labelling. 2008-2010. prof. S. Klimašauskas |
WELLCOME FONDAS
|
Cross-talk between functional domains of BfiI restriction endonuclease. 2005-2006. prof. dr. V. Šikšnys |
|
Restriction enzymes with novel restriction mechanisms. 2001-2003. prof. dr. V. Šikšnys |
|
Calorimetric Studies of DNA- Restriction Enzyme Interactions. 1999-2001. prof. dr. V. Šikšnys |